These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 33791979)

  • 1. Functional Metabolomics and Chemoproteomics Approaches Reveal Novel Metabolic Targets for Anticancer Therapy.
    Shao C; Lu W; Hao H; Ye H
    Adv Exp Med Biol; 2021; 1280():131-147. PubMed ID: 33791979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma.
    Lucarelli G; Loizzo D; Franzin R; Battaglia S; Ferro M; Cantiello F; Castellano G; Bettocchi C; Ditonno P; Battaglia M
    Expert Rev Mol Diagn; 2019 May; 19(5):397-407. PubMed ID: 30983433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unveiling the mechanism of action of nature-inspired anti-cancer compounds using a multi-omics approach.
    Soares NC; Ali A; Srinivasulu V; Sharaf BM; Giddey AD; Okendo J; Al-Hroub HM; Semreen MH; Hamad M; Al-Tel TH
    J Proteomics; 2022 Aug; 265():104660. PubMed ID: 35728772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics, metabolic flux analysis and cancer pharmacology.
    Liang L; Sun F; Wang H; Hu Z
    Pharmacol Ther; 2021 Aug; 224():107827. PubMed ID: 33662451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics, metabolomics and metagenomics for type 2 diabetes and its complications.
    Wang N; Zhu F; Chen L; Chen K
    Life Sci; 2018 Nov; 212():194-202. PubMed ID: 30243649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the perturbed metabolic pathways associating with prostate cancer cells and anticancer affects of obacunone.
    Xie J; Zhang AH; Qiu S; Zhang TL; Li XN; Yan GL; Sun H; Liu L; Wang XJ
    J Proteomics; 2019 Aug; 206():103447. PubMed ID: 31326558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of AHCY as an Off-Target of Doxorubicin by Integrative Analysis of Photoaffinity Labeling Chemoproteomics and Untargeted Metabolomics.
    Qian S; Han Y; Zhang Y; Du Y; Li J; Yang X; Kang J
    Anal Chem; 2022 Dec; 94(49):17121-17130. PubMed ID: 36445716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics and proteomics technologies to explore the herbal preparation affecting metabolic disorders using high resolution mass spectrometry.
    Zhang A; Zhou X; Zhao H; Zou S; Ma CW; Liu Q; Sun H; Liu L; Wang X
    Mol Biosyst; 2017 Jan; 13(2):320-329. PubMed ID: 28045158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics and Metabolic Reprogramming in Kidney Cancer.
    Weiss RH
    Semin Nephrol; 2018 Mar; 38(2):175-182. PubMed ID: 29602399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics and metabolomics characterizing the pathophysiology of adaptive reactions to the metabolic challenges during the transition from late pregnancy to early lactation in dairy cows.
    Ceciliani F; Lecchi C; Urh C; Sauerwein H
    J Proteomics; 2018 Apr; 178():92-106. PubMed ID: 29055723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of proteomics and metabolomics in microbial metabolic engineering].
    Yu W; Gao J; Zhou Y
    Se Pu; 2019 Aug; 37(8):798-805. PubMed ID: 31642249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
    Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics and cellular altered pathways in cancer biology: A review.
    Bhardwaj JK; Siwach A; Sachdeva SN
    J Biochem Mol Toxicol; 2024 Sep; 38(9):e23807. PubMed ID: 39148273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Omics" in oral cancer: New approaches for biomarker discovery.
    Rai V; Mukherjee R; Ghosh AK; Routray A; Chakraborty C
    Arch Oral Biol; 2018 Mar; 87():15-34. PubMed ID: 29247855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics of Gastric Cancer.
    Kadam W; Wei B; Li F
    Adv Exp Med Biol; 2021; 1280():291-301. PubMed ID: 33791990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Trends in Cancer Biomarker Discovery Using Urinary Metabolomics: Achievements and New Challenges.
    Burton C; Ma Y
    Curr Med Chem; 2019; 26(1):5-28. PubMed ID: 28914192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and Proteomics.
    Srivastava A; Creek DJ
    Proteomics; 2019 May; 19(10):e1700448. PubMed ID: 30353665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OMICS insights into cancer histology; Metabolomics and proteomics approach.
    Tayanloo-Beik A; Sarvari M; Payab M; Gilany K; Alavi-Moghadam S; Gholami M; Goodarzi P; Larijani B; Arjmand B
    Clin Biochem; 2020 Oct; 84():13-20. PubMed ID: 32589887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel personalized pathway-based metabolomics models reveal key metabolic pathways for breast cancer diagnosis.
    Huang S; Chong N; Lewis NE; Jia W; Xie G; Garmire LX
    Genome Med; 2016 Mar; 8(1):34. PubMed ID: 27036109
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.